Collection of Samples USOPTIVAL Study

Last updated: November 5, 2025
Sponsor: Universal Diagnostics
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel

Clinical Study ID

NCT04792684
CRC-US-001
  • Ages 45-84
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Arm A:

  1. Must be 45-84 years of age.

  2. Must have a suspected advanced adenoma or be newly diagnosed with CRC, still notresected, and scheduled for surgery.

  3. Able to comprehend, sign, and date the written informed consent document.

Arm B:

  1. Must be 45-84 years of age.

  2. Able and willing to undergo a standard-of-care screening colonoscopy within 60 days.

  3. Able to comprehend, sign, and date the written informed consent document.

Exclusion

Exclusion Criteria:

Arm A Only:

  1. Subject with curative biopsy during colonoscopy.

Arm B Only:

  1. Subjects with positive FIT Test results in the 6 months preceding enrollment.

  2. Subject has a current diagnosis of cancer.

Arms A & B:

  1. Subject has a personal history of aerodigestive or digestive tract cancers.

  2. Subjects having undergone previous partial surgical removal of one or more portionsof their colon due to a reason other than colorectal cancer.

  3. Has a known diagnosis or personal history of any of the following high-riskindications for colorectal cancer:

  4. Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) andCrohn's disease.

  5. Familial adenomatous polyposis ("FAP", including attenuated FAP).

  6. Hereditary non-polyposis colorectal cancer syndrome ("HNPCC" or "LynchSyndrome").

  7. Serrated polyposis syndrome

  8. 2 first-degree relatives (e.g., parents, siblings, and offspring) who have beendiagnosed with colon cancer.

  9. One first-degree relative with CRC diagnosed before the age of 60.

  10. A significant disease which, in the Investigator's opinion, would exclude thesubject from the study.

  11. Legal incapacity or limited mental capacity.

  12. Medical or psychological conditions that would not permit the subject to completethe study or sign informed consent.

  13. The patient has a known or documented previous or current medical history ofinfectious diseases that can be transmitted through blood (E.g. Hepatitis, HIV,etc.), including patients that have been treated, are currently being treated, orhave not been treated for that conditions.

  14. The patient is known to be pregnant when recruited or during her participation inthe study.

Study Design

Total Participants: 1300
Treatment Group(s): 1
Primary Treatment: Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Phase:
Study Start date:
December 30, 2020
Estimated Completion Date:
December 30, 2025

Study Description

This study is designed to prospectively collect blood samples and clinical data from subjects that have a suspected advanced adenoma or have been newly diagnosed with CRC scheduled for resection surgery, as well as subjects who are at average-risk of colorectal cancer and who are scheduled for routine colonoscopy examination.

Subjects interested in participation and who meet inclusion criteria and provide written informed consent will be enrolled in the study. By accepting participation in the study, subjects will consent to provide up to 40 ml of blood at the study visit.

Connect with a study center

  • Precision Recearch Institute

    Chula Vista, California 91910
    United States

    Site Not Available

  • Medical Associates Research Group

    San Diego, California 92123
    United States

    Completed

  • Precision Research Institute

    San Diego, California 92114
    United States

    Site Not Available

  • Clinical Research of California

    Walnut Creek, California 94598
    United States

    Site Not Available

  • Precision Recearch Institute

    Chula Vista 5336899, California 5332921 91910
    United States

    Completed

  • Medical Associates Research Group

    San Diego 5391811, California 5332921 92123
    United States

    Completed

  • Precision Research Institute

    San Diego 5391811, California 5332921 92114
    United States

    Completed

  • Clinical Research of California

    Walnut Creek 5406990, California 5332921 94598
    United States

    Completed

  • Center for Gastrointestinal Disorders

    Hollywood, Florida 33021
    United States

    Site Not Available

  • Lakeland Regional Cancer Center

    Lakeland, Florida 33805
    United States

    Site Not Available

  • Center for Gastrointestinal Disorders

    Hollywood 4158928, Florida 4155751 33021
    United States

    Completed

  • Lakeland Regional Cancer Center

    Lakeland 4161438, Florida 4155751 33805
    United States

    Active - Recruiting

  • Springfield Clinic

    Springfield, Illinois 62702
    United States

    Site Not Available

  • Springfield Clinic

    Springfield 4250542, Illinois 4896861 62702
    United States

    Active - Recruiting

  • Ochsner Clinic

    New Orleans, Louisiana 70121
    United States

    Site Not Available

  • Ochsner Clinic

    New Orleans 4335045, Louisiana 4331987 70121
    United States

    Completed

  • Dana Farber Cancer Institute

    Boston, Massachusetts 02215
    United States

    Site Not Available

  • Dana Farber Cancer Institute

    Boston 4930956, Massachusetts 6254926 02215
    United States

    Completed

  • Mid Hudson Medical Research

    New Windsor, New York 12553
    United States

    Site Not Available

  • Mid Hudson Medical Research

    New Windsor 5128577, New York 5128638 12553
    United States

    Active - Recruiting

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania 19111
    United States

    Completed

  • University of Pennsylvania

    Philadelphia, Pennsylvania 19104
    United States

    Site Not Available

  • Frontier Clinical Research

    Uniontown, Pennsylvania 15401
    United States

    Site Not Available

  • Fox Chase Cancer Center

    Philadelphia 4560349, Pennsylvania 6254927 19111
    United States

    Completed

  • University of Pennsylvania

    Philadelphia 4560349, Pennsylvania 6254927 19104
    United States

    Active - Recruiting

  • Frontier Clinical Research

    Uniontown 4561859, Pennsylvania 6254927 15401
    United States

    Completed

  • Clinical Trials Network

    Union City, Tennessee 38261
    United States

    Site Not Available

  • Clinical Trials Network

    Union City 4664170, Tennessee 4662168 38261
    United States

    Completed

  • Vilo Research Group

    Houston, Texas 77017
    United States

    Site Not Available

  • Vilo Research Group

    Houston 4699066, Texas 4736286 77017
    United States

    Completed

  • Gastroenterology Consultants of SW Virginia

    Roanoke, Virginia 24014
    United States

    Site Not Available

  • Gastroenterology Consultants of SW Virginia

    Raonoke, Virginia 6254928 24014
    United States

    Completed

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.